Pharmacology, Toxicology and Pharmaceutical Science
mRNA Vaccine
100%
Messenger RNA
75%
Infection
73%
Antibiotics
54%
Nanoemulsion
53%
Amoxicillin
48%
Streptococcus Pneumonia
48%
Vaccine Development
36%
Receptor
36%
Streptococcus
36%
Tuberculosis
30%
Vaccine
30%
HIV
30%
Flagellin
30%
Toll Like Receptor 5
30%
Pneumonia
30%
BCG Vaccine
30%
Phosphoryl Lipid A
30%
Antibiotic Therapy
30%
Messenger RNA
26%
Dermatophagoides
24%
Nanoemulsion
23%
Influenza Virus
21%
Pneumococcal Infection
21%
Respiratory Tract Infection
18%
Toll Like Receptor 4
18%
Immunogenicity
16%
Mycobacterium Tuberculosis
16%
Mycobacterium Bovis BCG
15%
Mixed Infection
15%
Superinfection
12%
Toll Like Receptor
12%
Respiratory Tract
12%
Mouse Model
12%
Bacterial Infection
12%
Infectious Agent
11%
Cytotoxicity
11%
Disease
11%
Mycobacterium Bovis BCG
9%
Mycobacterium Tuberculosis
6%
Infection
6%
Bacterial Clearance
6%
Virus Infection
6%
Antibacterial Activity
6%
Inflammation
6%
Transcription Factors
6%
Chemokine
6%
Antibiotic-Resistant Bacteria
6%
Cotrimoxazole
6%
Primary Infection
6%
Immunology and Microbiology
Pneumococcus
66%
Nanoemulsion
60%
Streptococcus Pneumonia
48%
Superinfection
42%
Influenza
36%
Infectious Agent
34%
Interleukin 1
30%
Phosphoryl Lipid A
30%
Th2 Cell
30%
BCG Vaccine
30%
Toll-Like Receptor
30%
Pulmonary Inflammation
30%
Cytokine
30%
Essential Gene
30%
Flagellin
30%
Serotype
30%
Innate Immune System
27%
Infectious Disease
23%
Mycobacterium Tuberculosis
23%
Homeostasis
22%
Influenza Virus
21%
Mycobacterium Bovis BCG
20%
Dermatophagoides
20%
CD4
20%
Immunity
18%
TLR4
18%
Cytotoxicity
16%
T Helper 17 Cell
15%
Cell Maturation
15%
Immune Response
15%
Normal Human
15%
Pneumococcal Vaccine
15%
Cell Wall
15%
Human Pathogen
15%
Antigenicity
15%
Viral Disease
15%
Adaptive Immune System
15%
Coinfection
15%
Immunology
15%
Antibodies
15%
Immunocompetent Cell
13%
Inflammatory Disorder
12%
Mouse Model
12%
Adoptive Immunity
11%
Immunogenicity
11%
COVID-19
11%
Genetic Transfection
11%
Humoral Immunity
11%
Macrophage
11%
Interleukin 1 Family
7%